Screener
BioLife Solutions BLFS Deferred Revenue
Deferred Revenue at other companies
Other financials
Where this comes from
Reported directly by BioLife Solutions in its filing.
Tagged under the XBRL concept us-gaap:ContractWithCustomerLiabilityCurrent.
The source filing: BioLife Solutions’s 10-Q, filed August 6, 2026. Open the filing →
- Filed
- Aug 6, 2026, 4:22 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001628280-26-054355
FAQ
- What is BioLife Solutions's deferred revenue?
- BioLife Solutions (BLFS) reported deferred revenue of $188K in Q2 2026.
- How has BioLife Solutions's deferred revenue changed year-over-year?
- BioLife Solutions's deferred revenue increased by 16.0% year-over-year, from $162K to $188K.
- What is the long-term trend for BioLife Solutions's deferred revenue?
- Over 3 years (2022 to 2025), BioLife Solutions's deferred revenue has grown at a -29.1% compound annual growth rate (CAGR), from $548K to $195K.
- What does deferred revenue mean?
- Payments received from customers for goods or services to be delivered within one year — recognized as revenue as performance obligations are satisfied.
Ask your AI about BioLife Solutions's deferred revenue.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude